BIAF Stock Analysis: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$3.54
-0.46 (-11.50%)
▼
5d:
-25.16%
30d:
+233.96%
90d:
+202.56%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BIAF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BIAF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $3.54, which is considered extended relative to its 30-day fair value range of $0.76 to $3.31.
Technical Outlook: Technically, BIAF is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $5.38. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: BIAF has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+69.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIAF is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $5.38. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: BIAF has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+69.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.76 -
$3.31
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price extended above range (+6.9% above fair value)
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-11.5%)
- BULLISH: Trading 69.5% below Wall St target ($6.00)
- CAUTION: 5-day price weakness (-25.2%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.76 -
$3.31
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$5.38
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.44
Wall Street Target
$6.00
(+69.5%)
Revenue Growth (YoY)
-27.8%
Profit Margin
-242.0%
Share & Embed Analysis
Last updated: March 30, 2026 6:10 PM ET
Data refreshes hourly during market hours. Next update: 7:10 PM
Data refreshes hourly during market hours. Next update: 7:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 61 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 54 HOLD |
